|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - LA JOLLA PHARMACEUTICAL CO (LJPC)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-14 Option Award |
2019-06-18 4:45 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer |
193 | $8.25 | 1,319 (Direct) |
View |
| 2019-06-14 Option Award |
2019-06-18 4:45 pm |
N/A 2029-06-14 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer |
193 | $9.71 | 1,319 (Direct) |
View |
| 2019-06-14 Option Award |
2019-06-18 4:44 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
193 | $8.25 | 2,592 (Direct) |
View |
| 2019-06-14 Option Award |
2019-06-18 4:44 pm |
N/A 2029-06-14 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
193 | $9.71 | 2,592 (Direct) |
View |
| 2019-06-14 Option Award |
2019-06-18 4:44 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
96 | $8.25 | 78,520 (Direct) |
View |
| 2019-06-14 Option Award |
2019-06-18 4:44 pm |
N/A 2029-06-14 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
96 | $9.71 | 78,520 (Direct) |
View |
| 2019-06-14 Option Award |
2019-06-18 4:44 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
69 | $8.25 | 5,911 (Direct) |
View |
| 2019-06-14 Option Award |
2019-06-18 4:44 pm |
N/A 2029-06-14 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
69 | $9.71 | 5,911 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-03 7:27 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
126 | $4.58 | 5,842 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-03 7:27 pm |
N/A 2029-05-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
126 | $5.39 | 5,842 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-03 7:27 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
174 | $4.58 | 78,424 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-03 7:27 pm |
N/A 2029-05-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
174 | $5.39 | 78,424 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-03 7:26 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer |
347 | $4.58 | 1,126 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-03 7:26 pm |
N/A 2029-05-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer |
347 | $5.39 | 1,126 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-03 7:26 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
347 | $4.58 | 2,399 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-03 7:26 pm |
N/A 2029-05-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
347 | $5.39 | 2,399 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 4:07 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
143 | $5.58 | 78,250 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 4:07 pm |
N/A 2029-05-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
143 | $6.57 | 78,250 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 4:07 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer |
285 | $5.58 | 779 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 4:07 pm |
N/A 2029-05-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer |
285 | $6.57 | 779 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 4:06 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
102 | $5.58 | 5,716 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 4:06 pm |
N/A 2029-05-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
102 | $6.57 | 5,716 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 4:06 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
285 | $5.58 | 2,052 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 4:06 pm |
N/A 2029-05-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
285 | $6.57 | 2,052 (Direct) |
View |
| 2019-04-30 Option Award |
2019-05-02 5:12 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
233 | $6.84 | 1,767 (Direct) |
View |
| 2019-04-30 Option Award |
2019-05-02 5:12 pm |
N/A 2029-04-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
233 | $8.05 | 1,767 (Direct) |
View |
| 2019-04-30 Option Award |
2019-05-02 5:11 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
116 | $6.84 | 78,107 (Direct) |
View |
| 2019-04-30 Option Award |
2019-05-02 5:11 pm |
N/A 2029-04-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
116 | $8.05 | 78,107 (Direct) |
View |
| 2019-04-30 Option Award |
2019-05-02 5:11 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
84 | $6.84 | 5,614 (Direct) |
View |
| 2019-04-30 Option Award |
2019-05-02 5:11 pm |
N/A 2029-04-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
84 | $8.05 | 5,614 (Direct) |
View |
| 2019-04-30 Option Award |
2019-05-02 5:10 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer |
233 | $6.84 | 494 (Direct) |
View |
| 2019-04-30 Option Award |
2019-05-02 5:10 pm |
N/A 2029-04-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer |
233 | $8.05 | 494 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
94 | $6.09 | 5,530 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 5:05 pm |
N/A 2029-04-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
94 | $7.16 | 5,530 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer |
261 | $6.09 | 261 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 5:05 pm |
N/A 2029-04-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer |
261 | $7.16 | 261 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 5:04 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
2 | $6.09 | 1,263,895 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 5:04 pm |
N/A 2029-04-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
2 | $7.16 | 1,263,895 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 5:02 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
261 | $6.09 | 1,534 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 5:02 pm |
N/A 2029-04-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
261 | $7.16 | 1,534 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 5:01 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
131 | $6.09 | 77,991 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 5:01 pm |
N/A 2029-04-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
131 | $7.16 | 77,991 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 7:08 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
146 | $5.47 | 77,860 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 7:08 pm |
N/A 2029-03-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
146 | $6.43 | 77,860 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 7:07 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
59 | $5.47 | 1,273 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 7:07 pm |
N/A 2029-03-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
59 | $6.43 | 1,273 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 7:07 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
94 | $5.47 | 1,263,893 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 7:07 pm |
N/A 2029-03-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
94 | $6.43 | 1,263,893 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 7:06 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
35 | $5.47 | 5,436 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 7:06 pm |
N/A 2029-03-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
35 | $6.43 | 5,436 (Direct) |
View |
| 2019-03-15 Option Award |
2019-03-19 5:08 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
195 | $6.49 | 1,263,799 (Direct) |
View |
| 2019-03-15 Option Award |
2019-03-19 5:08 pm |
N/A 2029-03-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
195 | $7.64 | 1,263,799 (Direct) |
View |
| 2019-03-15 Option Award |
2019-03-19 5:07 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
122 | $6.49 | 77,714 (Direct) |
View |
| 2019-03-15 Option Award |
2019-03-19 5:07 pm |
N/A 2029-03-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
122 | $7.64 | 77,714 (Direct) |
View |
| 2019-03-15 Option Award |
2019-03-19 5:06 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
29 | $6.49 | 5,401 (Direct) |
View |
| 2019-03-15 Option Award |
2019-03-19 5:06 pm |
N/A 2029-03-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
29 | $7.64 | 5,401 (Direct) |
View |
| 2019-03-15 Option Award |
2019-03-19 4:49 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
49 | $6.49 | 1,214 (Direct) |
View |
| 2019-03-15 Option Award |
2019-03-19 4:49 pm |
N/A 2029-03-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
49 | $7.64 | 1,214 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 5:33 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
261 | $4.85 | 1,263,604 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 5:33 pm |
N/A 2029-02-28 |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
261 | $5.7 | 1,263,604 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 5:32 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
164 | $4.85 | 77,592 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 5:32 pm |
N/A 2029-02-28 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
164 | $5.7 | 77,592 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 5:32 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
65 | $4.85 | 1,165 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 5:32 pm |
N/A 2029-02-28 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
65 | $5.7 | 1,165 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 5:31 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
40 | $4.85 | 5,372 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 5:31 pm |
N/A 2029-02-28 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
40 | $5.7 | 5,372 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 5:30 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
230 | $4.85 | 14,049 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 5:30 pm |
N/A 2029-02-28 |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
230 | $5.7 | 14,049 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-19 6:12 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
36 | $5.3 | 5,332 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-19 6:12 pm |
N/A 2029-02-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
36 | $6.23 | 5,332 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-19 6:11 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
60 | $5.3 | 1,100 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-19 6:11 pm |
N/A 2029-02-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
60 | $6.23 | 1,100 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-19 6:11 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
230 | $5.3 | 13,819 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-19 6:11 pm |
N/A 2029-02-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
230 | $6.23 | 13,819 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-19 6:10 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
239 | $5.3 | 1,263,343 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-19 6:10 pm |
N/A 2029-02-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
239 | $6.23 | 1,263,343 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-19 6:10 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
151 | $5.3 | 77,428 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-19 6:10 pm |
N/A 2029-02-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
151 | $6.23 | 77,428 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 6:14 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
1,260 | $5.13 | 13,589 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 6:14 pm |
N/A 2029-01-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
1,260 | $6.04 | 13,589 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 20 Jun 2019 10:24:30 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |